Centene Corporation
CNC Healthcare Healthcare Plans
Centene Corporation’s revenue for fiscal 2025 (year ended December 2025) was $194.8 billion, up 19.4% from fiscal 2024.
- Revenue
- +1.93%
- EPS
- +99.0%
- Free cash flow
- −437.4%
- Total debt
- −11.6%
Quarter to September 2026, against a year earlier
Follow CNC
Alert me
Centene Corporation (CNC) Return on equity
Centene Corporation's return on equity over the twelve months to 30 September 2026 was 6.74%, up 35.4 percentage points from fiscal 2025 (−28.7%). Over the past ten years it has ranged from −28.7% (fiscal 2025) to 18.2% (fiscal 2015) — the current reading is the lowest in ten years. That is below the Healthcare Plans industry median of 13.6% and above the Healthcare sector median of −26.0%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | −28.7% | (41.30) |
| FY2024 | 12.6% | 1.83 |
| FY2023 | 10.8% | 6.08 |
| FY2022 | 4.70% | (0.40) |
| FY2021 | 5.10% | (4.28) |
| FY2020 | 9.38% | (1.78) |
| FY2019 | 11.2% | 1.09 |
| FY2018 | 10.1% | (2.89) |
| FY2017 | 13.0% | (0.96) |
| FY2016 | 13.9% | (4.23) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| OSCR Oscar Health, Inc. compare | 52.6% |
| PGNY Progyny, Inc. compare | 18.7% |
| UNH UnitedHealth Group Incorporated compare | 15.4% |
| CVS CVS Health Corporation compare | 14.4% |
| CI Cigna Group compare | 14.0% |
| ELV Elevance Health, Inc. compare | 11.6% |
| CNC Centene Corporation | 6.74% |
| HUM Humana Inc. compare | 6.65% |
| MOH Molina Healthcare, Inc compare | −1.15% |
| Healthcare Plans industry median | 13.6% |
| Healthcare sector median | −26.0% |
| Market median | 1.01% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on CNC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement